Adipocytes play a critical role in metabolic homeostasis. Peroxisome proliferator-activated receptor- (PPAR ) is a nuclear hormone receptor that is a master regulator of adipocyte differentiation and function. ZBTB9 was predicted to interact with PPAR based on large-scale protein interaction experiments. In addition, GWAS studies in the type 2 diabetes (T2D) Knowledge Portal revealed associations between Z and both BMI and T2D risk. Here we show that ZBTB9 positively regulates PPAR activity in mature adipocytes. Surprisingly Z knockdown (KD) also increased adipogenesis in 3T3-L1 cells and human preadipocytes. activity was increased and E2F downstream target genes were upregulated in -KD preadipocytes. Accordingly, RB phosphorylation, which regulates E2F activity, was enhanced in -KD preadipocytes. Critically, an E2F1 inhibitor blocked the effects of deficiency on adipogenic gene expression and lipid accumulation. Collectively, these results demonstrate that inhibits adipogenesis as a negative regulator of expression via altered RB-E2F1 signaling. Our findings reveal complex cell-state dependent roles of ZBTB9 in adipocytes, identifying a new molecule that regulates adipogenesis and adipocyte biology as both a positive and negative regulator of PPAR signaling depending on the cellular context, and thus may be important in the pathogenesis and treatment of obesity and T2D.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10942320 | PMC |
http://dx.doi.org/10.1101/2024.03.04.583402 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!